Does PALBOCICLIB Cause White blood cell count increased? 180 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 180 reports of White blood cell count increased have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
180
Reports of White blood cell count increased with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
12
Deaths
37
Hospitalizations
How Dangerous Is White blood cell count increased From PALBOCICLIB?
Of the 180 reports, 12 (6.7%) resulted in death, 37 (20.6%) required hospitalization, and 3 (1.7%) were considered life-threatening.
Is White blood cell count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 180 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause White blood cell count increased?
CLOZAPINE (2,988)
ADALIMUMAB (1,710)
RUXOLITINIB (1,529)
IBRUTINIB (1,390)
RITUXIMAB (886)
METHOTREXATE (741)
PREDNISONE (716)
ETANERCEPT (615)
IMATINIB (520)
TOCILIZUMAB (478)
Which PALBOCICLIB Alternatives Have Lower White blood cell count increased Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID